Chitosan microspheres as a potential carrier for drugs

International Journal of Pharmaceutics

Volumn 274, Issue 1-2, 2004, Pages 1-33

  Sinha, V R ^a   Singla, A K ^a   Wadhawan, S ^a   Kaushik, R ^a   Kumria, R ^a   Bansal, K ^a   Dhawan, S ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Chitosan; Microspheres

Indexed keywords

ACICLOVIR; ALGINIC ACID; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBOXYMETHYLCELLULOSE; CARRAGEENAN; CENTRAL NERVOUS SYSTEM AGENTS; CHITOSAN; CHLORPHENIRAMINE MALEATE; CORTICOSTEROID; DIURETIC AGENT; DOCUSATE SODIUM; DRUG CARRIER; ETIDRONIC ACID; GASTROINTESTINAL AGENT; MACROGOL; MELATONIN; MICROSPHERE; NANOPARTICLE; PAMIDRONIC ACID; PREDNISOLONE SODIUM PHOSPHATE; STEROID; TRANSFORMING GROWTH FACTOR BETA1; TRIPOLYPHOSPHATE; UNINDEXED DRUG; XANTHAN;

ADHESION; ALGA; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; CROSS LINKING; DISSOLUTION; DRUG BLOOD LEVEL; DRUG COATING; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; EMULSION; GEL; GELATION; HUMAN; LIPID METABOLISM; MICROCAPSULE; MICROORGANISM; NONHUMAN; PLANT; PRIORITY JOURNAL; REVIEW; TOXICITY;

ANIMALS; CHITIN; CHITOSAN; DRUG CARRIERS; HUMANS; HYPERTENSION; INFECTION; MICROSPHERES; NEOPLASMS;

EID: 1842452953     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.12.026     Document Type: Review

References (205)

1. Acikgoz M., Kas H.S., Hascelik Z., Milli U., Hincal A.A. Chitosan microspheres of diclofenac sodium. II: In vitro and in vivo evaluation. Pharmazie. 50:1995;275-277.
2. Acikgoz M., Kas H.S., Orman M., Hincal A.A. Chitosan microspheres of diclofenac sodium: I. Application of factorial design and evaluation of release kinetics. J. Microencapsul. 13:1996;141-159.
3. Aggarwal A., Kaur S., Tiwary A.K., Gupta S. Chitosan microspheres prepared by an aqueous process: release of indomethacin. J. Microencapsul. 18:2001;819-823.
4. Aiedeh K., Gianasi E., Orienti E., Zecchi V. Chitosan microcapsules as controlled release systems for insulin. J. Microencapsul. 14:1997;567-576.
5. Akbuga J. Effect of the physicochemical properties of a drug on its release from chitosan malate matrix tablets. Int. J. Pharm. 100:1993;257-261.
6. Akbuga J., Bergisadi N. 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics. J. Microencapsul. 13:1996;161-168.
7. Akbuga J., Bergisadi N. Effect of formulation variables on cis-platin loaded chitosan microsphere properties. J. Microencapsul. 16:1999;697-703.
8. Akbuga J., Durmaz G. Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. Int. J. Pharm. 111:1994;217-222.
9. Alexakis T., Boadi D.K., Quong D., Groboillot A., O'Neill I., Poncelet D., Neufeld R.J. Microencapsulation of DNA within alginate microspheres and crosslinked chitosan membranes for in vivo application. Appl. Biochem. Biotechnol. 50:1995;93-106.
10. Al-Helw A.A., Al-Angary A.A., Mahrous G.M., Al-Dardari M.M. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone. J. Microencapsul. 15:1998;373-382.
11. al-Suwayeh S.A., el-Helw A.R., al-Mesned A.F., Bayomi M.A., el-Gorashi A.S. In vitro-in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride. Boll. Chim. Farm. 142:2003;14-20.
12. Amiji M.M. Permeability and blood compatibility properties of chitosan-poly(ethylene oxide) blend membranes for haemodialysis. Biomaterials. 16:1995;593-599.
13. Aral C., Ozbas-Turan S., Kabasakal L., Keyer-Uysal M., Akbuga J. Studies of effective factors of plasmid DNA-loaded chitosan microspheres. Part 1: Plasmid size, chitosan concentration & plasmid addition techniques. STP Pharm. Sci. 10:2000;83-88.
14. Aydin Z., Akbuga J. Chitosan beads for the delivery of salmon calcitonin: preparation and release characteristics. Int. J. Pharm. 131:1996;101-103.
15. Bayomi M.A., al-Suwayeh S.A., el-Helw A.M., Mesnad A.F. Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique. Pharm. Acta Helv. 73:1998;187-192.
16. Beena M.S., Chandy T., Sharma C.P. Phenyl alanine, tryptophan immobilized chitosan beads as adsorbents for selective removal of immunoproteins. J. Biomater. Appl. 8:1994;385-403.
17. Berscht P.C., Nies B., Liebendorfer A., Kreuter J. Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics. Biomaterials. 15:1994;593-600.
18. Berthold A., Cremer K., Kreuter J. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Control Rel. 39:1996a;17-25.
19. Berthold A., Cremer K., Kreuter J. Influence of crosslinking on the acid stability and physicochemical properties of chitosan microspheres. STP Pharm. Sci. 6:1996b;358-364.
20. Blanco M.D., Gomez C., Olmo R., Muniz E., Teijon J.M. Chitosan microspheres in PLG films as devices for cytarabine release. Int. J. Pharm. 202:2000;29-39.
21. Bodmeier R., Oh K.H., Pramar Y. Preparation and evaluation of drug-containing chitosan beads. Drug Dev. Ind. Pharm. 15:1989a;1475-1494.
22. Bodmeier R., Chen H.G., Paeratakul O. A novel approach to the oral delivery of micro-or nanoparticles. Pharm. Res. 6:1989b;413-417.
23. Bodmeier R., Paeratakul O. Spherical agglomerates of water-insoluble drugs. J. Pharm. Sci. 78:1989;964-967.
24. Bogataj M., Mrhar A., Grabnar I., Rajtman Z., Bukovec P., Srcic S., Urleb U. The influence of magnesium stearate on the characteristics of mucoadhesive microspheres. J. Microencapsul. 17:2000;499-508.
25. Burjak M., Bogataj M., Velnar M., Grabnar I., Mrhar A. The study of drug release from microspheres adhered on pig vesical mucosa. Int. J. Pharm. 224:2001;123-130.
26. Chandy T., Das G.S., Rao G.H. 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. J. Microencapsul. 17:2000;625-638.
27. Chandy T., Rao G.H., Wilson R.F., Das G.S. Development of poly(lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis. Drug Deliv. 8:2001;77-86.
28. Chandy T., Sharma C.P. Chitosan - as a biomaterial biomater. Artif. Cells Artif. Organs. 18:1990;1-24.
29. Chandy T., Sharma C.P. Biodegradable chitosan matrix for the controlled release of steroids. Biomater. Artif. Cells Immob. Biotechnol. 19:1991;745-760.
30. Chandy T., Sharma C.P. Polylysine-immobilized chitosan beads as adsorbents for bilirubin. Artif. Organs. 16:1992;568-576.
31. Chandy T., Sharma C.P. Chitosan matrix for oral sustained delivery of ampicillin. Biomaterials. 14:1993;939-944.
32. Chandy T., Wilson R.F., Rao G.H., Das G.S. Changes in cisplatin delivery due to surface-coated poly(lactic acid)-poly(epsilon-caprolactone) microspheres. J. Biomater. Appl. 16:2002;275-291.
33. Chellat F., Tabrizian M., Dumitriu S., Chornet E., Rivard C.H., Yahia L. Study of biodegradation behavior of chitosan-xanthan microspheres in simulated physiological media. J. Biomed. Mater. Res. 53:2000;592-599.
34. Chiou S.H., Wu W.T., Huang Y.Y., Chung T.W. Effects of the characteristics of chitosan on controlling drug release of chitosan coated PLLA microspheres. J. Microencapsul. 18:2001;613-625.
35. Daly M.M., Knorr D. Chitosan-alginate coacervate capsule: effect of calcium chloride Plastcizers and polyelectrolytes on mechanical stability. Biotechnol. Progr. 4:1988;76.
36. Dambies L., Vincent T., Domard A., Guibal E. Preparation of chitosan gel beads by ionotropic molybdate gelation. Biomacromolecules. 2:2001;1198-1205.
37. De S., Robinson D. Polymer relationships during preparation of chitosan-alginate and poly-L-lysine-alginate nanospheres. J. Control Rel. 89:2003;101-112.
38. Demarger-Andre, S., Domard, A., 1994. New properties of chitosan in lipid dispersions. In: Chitin World, Karnicki, Z.S., Wojtaso Pajak, A., Breziski, M.M., Bylowski, P.J. (Eds.), Bremerhauser, Germany, pp. 153-158.
39. Denkbas E.B., Seyyal M., Piskin E. 5-Fluorouracil loaded chitosan microspheres for chemoembolization. J. Microencapsul. 16:1999;741-749.
40. Dhawan S., Singla A.K. Nifedipine loaded chitosan microspheres prepared by emulsification phase separation. Biotech. Histochem. 78:2003;243-254.
41. Dini E., Alexandridou S., Kiparissides C. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications. J. Microencapsul. 20:2003;375-385.
42. Dodane V., Khan M.A., Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 182:1999;21-32.
43. Elcin Y.M., Dixit V., Gitnick G. Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies. Artif. Cells Blood Substit. Immobil. Biotechnol. 24:1996;257-271.
44. El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. Int. J. Pharm. 249:2002;7-21.
45. El-Shafy M.A., Kellaway I.W., Taylor G., Dickinson P.A. Improved nasal bioavailability of FITC-dextran (Mw 4300) from mucoadhesive microspheres in rabbits. J. Drug Target. 7:2000;355-361.
46. Farivar M., Kas H.S., Oner L., Hincal A.A. Isosorbide-5-mononitrate microspheres: formulation and evaluation of in vitro release profiles by application of factorial design. HU Ecz. Der. 13:1993;25-37.
47. Felt O., Buri P., Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24:1998;979-993.
48. Felt O., Furrer P., Mayer J.M., Plazonnet B., Buri P., Gurny R. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int. J. Pharm. 180:1999;185-193.
49. Fernandez-Urrusuno R., Calvo P., Remunan-Lopez C., Vila-Jato J.L., Alonso M.J. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 16:1999;1576-1581.
50. Filipovic-Grcic J., Becirevic-Lacan M., Skalko N., Jalsenjak I. Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes. Int. J. Pharm. 135:1996;183-190.
51. Filipovic-Grcic J., Maysinger D., Zorc B., Jalsenjak I. Macromolecular prodrugs. Part 4. Alginate-chitosan microspheres of PHEA-L-dopa adduct. Int. J. Pharm. 116:1995;39-44.
52. Filipovic-Grcic J., Perissutti B., Moneghini M., Voinovich D., Martinac A., Jalsenjak I. Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation. J. Pharm. Pharmacol. 55:2003;921-931.
53. Fukuda H. Polyelectrolyte complexes of chitosan carboxymethyl cellulose. Bull. Chem. Soc. Jpn. 53:1980;837-840.
54. Furda, I., 1980. Nonabsorbable lipid binder. US Patent 4,223,023.
55. Gallo J.M., Hassan E.E. Receptor-mediated magnetic carriers: basis for targeting. Pharm. Res. 5:1988;300-304.
56. Ganza-Gonzalez A., Anguiano-Igea S., Otero-Espinar F.J., Blanco Mendez J. Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide. Eur. J. Pharm. Biopharm. 48:1999;149-155.
57. Genta I., Conti B., Perugini P., Pavanetto F., Spadaro A., Puglisi G. Bioadhesive microspheres for ophthalmic administration of acyclovir. J. Pharm. Pharmacol. 49:1997;737-742.
58. Genta I., Pavanetto F., Conti B., Gunchedi P., Conte U. Improvement of dexamethasone dissolution rate from spray-dried chitosan microspheres. STP Pharm. Sci. 5:1995;202-207.
59. Genta I., Perugini P., Pavanetto F. Different molecular weight chitosan microspheres: influence on drug loading and drug release. Drug Dev. Ind. Pharm. 24:1998;779-784.
60. Giunchedi P., Genta I., Conti B., Muzzarelli R.A., Conte U. Preparation and characterization of ampicillin loaded methylpyrrolidinone chitosan and chitosan microspheres. Biomaterials. 19:1998;157-161.
61. Giunchedi P., Juliano C., Gavini E., Cossu M., Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur. J. Pharm. Biopharm. 53:2002;233-239.
62. Gohel M.C., Sheth M.N., Patel M.M., Jani G.K., Patel H. Design of chitosan microspheres containing diclofenac sodium. Ind. J. Pharm. Sci. 56:1994;210-214.
63. Gonzalez-Rodriguez M.L., Holgado M.A., Sanchez-Lafuente C., Rabasco A.M., Fini A. Alginate/chitosan particulate systems for sodium diclofenac release. Int. J. Pharm. 232:2002;225-234.
64. Goskonda S.R., Upadrashta S.M. Avicel RC-591/chitosan beads by extrusion spheronization technology. Drug Dev. Ind. Pharm. 19:1993;915-927.
65. Hari P.R., Chandy T., Sharma C.P. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J. Microencapsul. 13:1996;319-329.
66. Hassan E.E., Gallo J.M. Targeting anticancer drugs to the brain. I: Enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres. J. Drug Target. 1:1993;7-14.
67. Hassan E.E., Parish R.C., Gallo J.M. Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. Pharm. Res. 9:1992;390-397.
68. He P., Davis S.S., Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm. 166:1998;75-88.
69. He P., Davis S.S., Illum L. Chitosan microspheres prepared by spray drying. Int. J. Pharm. 187:1999a;53-65.
70. He P., Davis S.S., Illum L. Sustained release chitosan microspheres prepared by novel spray drying methods. J. Microencapsul. 16:1999b;343-355.
71. Hejazi R., Amiji M. Stomach-specific anti-H. pylori therapy. I: preparation and characterization of tetracyline-loaded chitosan microspheres. Int. J. Pharm. 235:2002;87-94.
72. Hejazi R., Amiji M. Stomach-specific anti-H. pylori therapy. II. Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbils. Pharm. Dev. Technol. 8:2003;253-262.
73. Hou W.M., Miyazaki S., Takada M., Komai T. Sustained release of indomethacin from chitosan granules. Chem. Pharm. Bull. (Tokyo). 33:1985;3986-3992.
74. Huang H., Tian, H., Li, X., Zhao, G., 2001. Hypoglycemic effect of chitosan-microcapsulated insulin on the blood glucose level of streptozotocin-diabetic Wistar rats. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 18, 425-427, 460.
75. Huang Y.C., Yeh M.K., Cheng S.N., Chiang C.H. The characteristics of betamethasone-loaded chitosan microparticles by spray-drying method. J. Microencapsul. 20:2003a;459-472.
76. Huang Y.C., Chiang C.H., Yeh M.K. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method. J. Microencapsul. 20:2003b;247-260.
77. Huang R.G., Schwartz J.B., Ofner C.M. III Microencapsulation of chlorpheniramine maleate-resin particles with crosslinked chitosan for sustained release. Pharm. Dev. Technol. 4:1999;107-115.
78. Huang Y., Yeh M., Chiang C. Formulation factors in preparing BTM-chitosan microspheres by spray drying method. Int. J. Pharm. 242:2002;239-242.
79. Huguet M.L., Groboillot A., Neufeld R.J., Poncelet D., Dellacherie E. Hemoglobin encapsulation in chitosan/calcium alginate beads. J. Appl. Polym. Sci. 51:1994;1427-1432.
80. Ilango R., Kavimani S., Premila J., Nair D.K., Jayakar B. Studies on tablets of sulphamethoxazole using chitosan. Ind. J. Pharm. Sci. 59:1997;220-224.
81. Illum L., Farraj N.F., Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11:1994;1186-1189.
82. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15:1998;1326-1331.
83. Illum L., Jabbal-Gill I., Hinchcliffe M., Fisher A.N., Davis S.S. Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev. 51:2001;81-96.
84. Illum L., Watts P., Fisher A.N., Hinchcliffe M., Norbury H., Jabbal-Gill I., Nankervis R., Davis S.S. Intranasal delivery of morphine. J. Pharmacol. Exp. Ther. 301:2002;391-400.
85. Ito M., Ban A., Ishihara M. Anti-ulcer effects of chitin and chitosan, healthy foods, in rats. Jpn. J. Pharmacol. 82:2000;218-225.
86. Itoyama K., Tokura S., Hayashi T. Lipoprotein lipase immobilization onto porous chitosan beads. Biotechnol. Progr. 10:1994;225-229.
87. Jameela S.R., Jayakrishnan A. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. Biomaterials. 16:1995;769-775.
88. Jameela S.R., Kumary T.V., Lal A.V., Jayakrishnan A. Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. J. Control Rel. 52:1998;17-24.
89. Jameela S.R., Latha P.G., Subramoniam A., Jayakrishnan A. Antitumour activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma. J. Pharm. Pharmacol. 48:1996;685-688.
90. Jameela S.R., Misra A., Jayakrishnan A. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J. Biomater. Sci. Polym. Ed. 6:1994;621-632.
91. Kas H.S. Chitosan: properties, preparation and application to microparticulate systems. J. Microencapsul. 14:1997;689-711.
92. Kato Y., Onishi H., Machida Y. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr. Pharm. Biotechnol. 4:2003;303-309.
93. Kawashima Y., Handa T., Kasai A., Takenaka H., Lin S.Y. The effects of thickness and hardness of the coating film on the drug release rate of theophylline granules coated with chitosan-sodium tripolyphosphate complex. Chem. Pharm. Bull. (Tokyo). 33:1985a;2469-2474.
94. Kawashima Y., Handa T., Kasai A., Takenaka H., Lin S.Y., Ando Y. Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan. J. Pharm. Sci. 74:1985b;264-268.
95. Kawashima Y., Yamamoto H., Takeuchi H., Kuno Y. Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm. Dev. Technol. 5:2000;77-85.
96. Kim, S.K., Rha, C., 1989a. Chitosan for the encapsulation of mammalian cell culture. In: Skjak-Braek, G., Anthonen, T., Sanford, P. (Eds.), Chitin and Chitosan-Sources, Chemistry, Biochemistry, Physical Properties and Application. Elsevier, London, pp. 617-626.
97. Kim, S.K., Rha, C., 1989b. Transdermal permeation of proteins in chitosan capsules. In: Skjak-Braek, G., Anthonen, T., Sanford, P. (Eds.), Chitin and Chitosan-Sources, Chemistry, Physical Properties and Application. Elsevier, London, pp. 365-642.
98. Kim S.E., Park J.H., Cho Y.W., Chung H., Jeong S.Y., Lee E.B., Kwon I.C. Porous chitosan scaffold containing microspheres loaded with transforming growth factor-beta1: implications for cartilage tissue engineering. J. Control Rel. 91:2003;365-374.
99. Ko J.A., Park H.J., Hwang S.J., Park J.B., Lee J.S. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int. J. Pharm. 249:2002;165-174.
100. Kockisch S., Rees G.D., Young S.A., Tsibouklis J., Smart J.D. Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential. J. Pharm. Sci. 92:2003;1614-1623.
101. Kofuji K., Ito T., Murata Y., Kawashima S. The controlled release of a drug from biodegradable chitosan gel beads. Chem. Pharm. Bull. (Tokyo). 48:2000;579-581.
102. Kofuji K., Shibata K., Murata Y., Miyamoto E., Kawashima S. Preparation and drug retention of biodegradable chitosan gel beads. Chem. Pharm. Bull. (Tokyo). 47:1999;1494-1496.
103. Kotze A.F., Lueβen H.L., de Leeuw B.J., de Boer A.G., Verhoef J.C., Junginger H.E. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J. Control Rel. 51:1998;35-46.
104. Kristl J., Smidx-Korbar J., Struc E., Schara M., Rupprecht H. Hydrocolloids and gels of chitosan as drug carriers. Int. J. Pharm. 99:1993;13-19.
105. Kristmundsdottir T., Ingvarsdottir K., Saemundsdottir G. Chitosan matrix tablets: the influence of excipients on drug release. Drug Dev. Ind. Pharm. 21:1995;1591-1598.
106. Kumar V., Lewis S.A., Mutalik S., Shenoy D.B., Udupa N. Biodegradable microspheres of curcumin for treatment of inflammation. Indian J. Physiol. Pharmacol. 46:2002;209-217.
107. Kumbar S.G., Kulkarni A.R., Aminabhavi M. Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent. J. Microencapsul. 19:2002;173-180.
108. Kyotani S., Nishioka Y., Okamura M., Tanaka T., Miyazaki M., Ohnishi S., Yamamoto Y., Ito K., Ogiso T., Tanada S. A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: antitumor effect of cis-diamminedichloroplatinum(II) albumin microspheres, containing chitin and treated with chitosan on rabbits with VX2 hepatic tumors. Chem. Pharm. Bull. (Tokyo). 40:1992;2814-2816.
109. Lee B.J., Choe J.S., Kim C.K. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres. J. Microencapsul. 15:1998;775-787.
110. Lehr C.M., Bouwstra J.A., Schacht E.H., Junginger H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78:1992;43-48.
111. Li X. The use of chitosan to increase the stability of calcium alginate beads with entrapped yeast cells. Biotechnol. Appl. Biochem. 23:1996;269-272.
112. Li Y.P., Machida T.Y., Sannan T., Nagai T. Preparation of chitosan microspheres containing fluorouracil using the 'dry-in-oil' method and its release characteristics. STP Pharm. Sci. 1:1991;363-368.
113. Lim L.Y., Wan L.S. Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique. J. Microencapsul. 15:1998;319-333.
114. Lim L.Y., Wan L.S., Thai P.Y. Chitosan microspheres prepared by emulsification and ionotropic gelation. Drug Dev. Ind. Pharm. 23:1997;981-985.
115. Lim S.T., Martin G.P., Berry D.J., Brown M.B. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J. Control Rel. 66:2000;281-292.
116. Lin S.Y., Lin P.C. Influence of sodium bicarbonate and sodium tripolyphosphate and the adding sequence on the formation and dissolution of theophylline chitosan microcapsules. STP Pharm. Sci. 2:1992;500-505.
117. Lin W.J., Kang W.W. Comparison of chitosan and gelatin coated microparticles: prepared by hot-melt method. J. Microencapsul. 20:2003;169-177.
118. Liu L.S., Liu S.Q., Ng S.Y., Froix M., Heller J. Controlled release of interleukin 2 for tumor immunotherapy using alginate/chitosan porous microspheres. J. Control Rel. 43:1997;65-74.
119. Lorenzo-Lamosa M.L., Remunan-Lopez C., Vila-Jato J.L., Alonso M.J. Design of microencapsulated chitosan microspheres for colonic drug delivery. J. Control Rel. 52:1998;109-118.
120. Lucinda-Silva R.M., Evangelista R.C. Microspheres of alginate-chitosan containing isoniazid. J. Microencapsul. 20:2003;145-152.
121. Lueβen H.L., Lehr C.M., Rentel C.O., Noach A.B.J., de Boer A.G., Verhoef J.C., Junginger H.E. Bioadhesive polymers for the peroral delivery of peptide drugs. J. Control Rel. 29:1994;329-338.
122. Magdassi S., Bach U., Mumcuoglu K.Y. Formation of positively charged microcapsules based on chitosan-lecithin interactions. J. Microencapsul. 14:1997;189-195.
123. Markey, M.L., Bowman, L.N., Bergamini, M.V.M., 1989. Chitin and Chitosan-Source, Chemistry, Biochemistry, Physical Properties and Application. Elsevier, London.
124. Martinac A., Filipovic-Grcic J., Barbaric M., Zorc B., Voinovich D., Jalsenjak I. Gemfibrozil encapsulation and release from microspheres and macromolecular conjugates. Eur. J. Pharm. Sci. 17:2002;207-216.
125. Meshali M.M., Gabr K.E. Effect of interpolymer complex formation of chitosan with pectin or acacia on the release behavior of chlorpromazine HCl. Int. J. Pharm. 89:1993;177-181.
126. Mi F.L., Shyu S.S., Chen C.T., Schoung J.Y. Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro release. Biomaterials. 20:1999;1603-1612.
127. Mi F.L., Wong T.B., Shyu S.S. Sustained-release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening methods. J. Microencapsul. 14:1997;577-591.
128. Mi F.L., Tan Y.C., Liang H.F., Sung H.W. In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials. 23:2002;181-191.
129. Miglani (Dhawan), S., 2002. Preparation and evaluation of controlled release oral dosage forms of glipizide and nifedipine. Ph.D. thesis, University Institute of Pharmaceutical Sciences, Punjab University, Chandigarh.
130. Miguez M.J., Rodrigues B.C., Sanchez Mde N., Laranjeira M.C. Preparation and scanning electronic microscopy study of chitosan/polyvinyl (alcohol)-encapsulated crude urease extract. J. Microencapsul. 14:1997;639-646.
131. Mitani T., Tamashita T., Okaumura C., Ishii H. Adsorption of benzoic acid and its derivatives to swollen chitson beads. Biosci. Biotech. Biochem. 59:1995;927-928.
132. Mittal S., Cohen A., Maysinger D. In vitro effects of brain derived neurotrophic factor released from microspheres. Neuroreport. 5:1994;2577-2582.
133. Miyazaki S., Ishii K., Nadai T. Use of chitin and chitosan as drug carriers. Chem. Pharm. Bull. 29:1981;3067-3069.
134. Miyazaki T., Komuro T., Yomota C., Okada S. Use of chitosan as a pharmaceutical material effectiveness as an additional additive of sodium alginate. Eisei Shikenjo Hokoku. 108:1990;95-97.
135. Mooren F.C., Berthold A., Domschke W., Kreuter J. Influence of chitosan microspheres on the transport of prednisolone sodium phosphate across HT-29 cell monolayers. Pharm. Res. 15:1998;58-65.
136. Murata Y., Maeda T., Miyamoto E., Kawashima S. Preparation of chitosan-reinforced alginate gel beads - effects of chitosan on gel matrix erosion. Int. J. Pharm. 96:1993;139-145.
137. Murata Y., Miyamoto E., Kawashima S. Additive effect of chondroitin sulfate and chitosan on drug release from calcium-induced alginate gel beads. J. Control Rel. 38:1996;101-108.
138. Muzzarelli, R.A.A., 1994. Morophogenetic action of chitosan and growth factors-fibroblast encapsulation in chitosan gel. In: Proceedings of Workshop on Cell Cultures, Italy.
139. Muzzarelli, R.A.A., 1977. Chitin. Pergamon Press, New York, pp. 1-37.
140. Nagyuvary, J.J., 1982. Treating hyperbilirubinemia. US Patent 4,363,801.
141. Nascimento A., Laranjeira M.C., Favere V.T., Josue A. Impregnation and release of aspirin from chitosan/poly(acrylic acid) graft copolymer microspheres. J. Microencapsul. 18:2001;679-684.
142. Nigalaye A.G., Adusumilli P., Bolton S. Investigation of prolonged drug release from matrix formulations of chitosan. Drug Dev. Ind. Pharm. 16:1990;449-467.
143. Needleman I.G., Smales F.C. In vitro assessment of bioadhesion for periodontal and buccal drug delivery. Biomaterials. 16:1995;617-624.
144. Nishimura K., Nishimura S., Seo H., Nishi N.M., Tokura I. Macrophage attraction with multiporous beads prepared from practically deacetylated chitin. J. Biomed. Mater. Res. 20:1986;1359-1372.
145. Nishioka Y., Kyotani S., Masui H., Okamura M., Miyazaki M., Okazaki K., Ohnishi S., Yamamoto Y., Ito K. Preparation and release characteristics of cisplatin albumin microspheres containing chitin and treated with chitosan. Chem. Pharm. Bull. (Tokyo). 37:1989;3074-3077.
146. Nishioka Y., Kyotani S., Okamura M., Miyazaki M., Okazaki K., Ohnishi S., Yamamoto Y., Ito K. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. Chem. Pharm. Bull. (Tokyo). 38:1990;2871-2873.
147. Nsereko S., Amiji M. Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations. Biomaterials. 23:2002;2723-2731.
148. Ohtakara, A., Mukerjee, G., Mitsutomi, M., 1989a. Immobilization of alphagalactosidase and glucoamylases on crosslined chitosan beads. In: Chitin and Chitosan-Source, Chemistry. Biomed. Mater Res. 20, 1359-1375.
149. Ohtakara, A., Mukerjee, G., Mitsutomi, M., 1989b. Immobilization of alphagalactosidase and glucoamylases on crosslined chitosan beads. In: Skjak-Braek, G., Anthonsen, T., Sanford, P. (Eds.), Chitin and Chitosan-Source, Chemistry, Biochemistry, Physical Properties and Application. Elsevier, London, pp. 643-652.
150. Ohya Y., Takei T., Kobayashi H., Ouchi T. Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. J. Microencapsul. 10:1993;1-9.
151. Onsoyen E., Skaugrud O. Metal recovery using chitosan. J. Chem. Technol. Biotechnol. 49:1990;395-404.
152. Orienti I., Aiedeh K., Gianasi E., Bertasi V., Zecchi V. Indomethacin loaded chitosan microspheres. Correlation between the erosion process and release kinetics. J. Microencapsul. 13:1996;463-472.
153. Ozbas-Turan S., Akbuga J., Aral C. Controlled release of interleukin-2 from chitosan microspheres. J. Pharm. Sci. 91:2002;1245-1251.
154. Ozbas-Turan S., Aral C., Kabasakal L., Keyer-Uysal M., Akbuga J. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle. J. Pharm. Pharm. Sci. 6:2003;27-32.
155. Pandya Y., Knorr D. Diffusion characteristics and properties of chitosan coacervate capsules. Proc. Biochem. 26:1991;75-81.
156. Patashnik S., Rabinovich L., Golomb G. Preparation and evaluation of chitosan microspheres containing bisphosphonates. J. Drug Target. 4:1997;371-380.
157. Pavanetto F., Perugini P., Conti B., Modena T., Genta I. Evaluation of process parameters involved in chitosan microsphere preparation by the o/w/o multiple emulsion method. J. Microencapsul. 13:1996;679-688.
158. Polk A., Amsden B., De Yao K., Peng T., Goosen M.F. Controlled release of albumin from chitosan-alginate microcapsules. J. Pharm. Sci. 83:1994;178-185.
159. Portero A., Remunan-Lopez C., Criado M.T., Alonso M.J. Reacetylated chitosan microspheres for controlled delivery of anti-microbial agents to the gastric mucosa. J. Microencapsul. 19:2002;797-809.
160. Queen M.C., Silvia C., Lai A., Amiji P.M.C. Surface & blood interaction properties of polyethylene oxide modified chitosan microspheres. STP Pharm. Sci. 10:2000;95-100.
161. Ramdas M., Dileep K.J., Anitha Y., Paul W., Sharma C.P. Alginate encapsulated bioadhesive chitosan microspheres for intestinal drug delivery. J. Biomater. Appl. 13:1999;290-296.
162. Remunan-Lopez C., Lorenzo-Lamosa M.L., Vila-Jato J.L., Alonso M.J. Development of new chitosan-cellulose multicore microparticles for controlled drug delivery. Eur. J. Pharm. Biopharm. 45:1998;49-56.
163. Ribeiro A.J., Neufeld R.J., Arnaud P., Chaumeil J.C. Microencapsulation of lipophilic drugs in chitosan-coated alginate microspheres. Int. J. Pharm. 187:1999;115-123.
164. Rillosi M., Buckton G. Modelling mucoadhesion by use of surface energy terms obtained from the Lewis acid-Lewis base approach. II. Studies on anionic, cationic and unionisable polymers. Pharm. Res. 12:1995;669-675.
165. Roberts, G.A.F., 1992. Chitin Chemistry. Mac Millian Press, Houndmills, pp. 1-50.
166. Sabnis S., Rege P., Block L.H. Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. Pharm. Dev. Technol. 2:1997;243-255.
167. Sankar C., Rani M., Srivastava A.K., Mishra B. Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation. Pharmazie. 56:2001;223-226.
168. Sawayanagi Y., Nambu N., Nagai T. Enhancement of dissolution properties of griseofulvin from ground mixtures with chitin and chitosan. Chem. Pharm. Bull. 30:1982a;4464-4467.
169. Sawayanagi Y., Nambu N., Nagai T. Permeation of drugs through chitosan membranes. Chem. Pharm. Bull. 30:1982b;3297-3301.
170. Sawayanagi Y., Nambu N., Nagai T. Dissolution properties and bioavailability of phenytoin from ground mixtures with chitin or chitosan. Chem. Pharm. Bull. (Tokyo). 31:1983;2064-2068.
171. Schipper N.G.M., Varum K.M., Artursson P. Chitosan as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human epithelial (Caco-2) cells. Pharm. Res. 13:1996;1686-1692.
172. Schipper N.G.M., Olsson S., Hoogstraate J.A., de Boer A.G., Varum K.M., Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs. 2: Mechanism of absorption enhancement. Pharm. Res. 14:1997;923-929.
173. Sezer A.D., Akbuga J. Controlled release of piroxicam from chitosan beads. Int. J. Pharm. 121:1995;113-116.
174. Shah S., Qaqish R., Patel V., Amiji M. Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection. J. Pharm. Pharmacol. 51:1999;667-672.
175. Shimoda J., Onishi H., Machida Y. Bioadhesive characteristics of chitosan microspheres to the mucosa of rat small intestine. Drug Dev Ind. Pharm. 27:2001;567-576.
176. Shioya, T., Rha, C., 1989. Tramsmembrane permeability of chitosan/carboxymethyl cellulose capsules. In: Skjak-Braek, G., Anthonsen, T., Sanford, P. (Eds.), Chitin and Chitosan-Source, Chemistry, Biochemistry, Physical Properties and Application. Elsevier, London, pp. 627-634.
177. Shiraishi S., Arahira M., Imai T., Otagiri M. Enhancement of dissolution rates of several drugs by low-molecular weight chitosan and alginate. Chem. Pharm. Bull. 38:1990;185-187.
178. Shiraishi S., Imai T., Otagiri M. Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation. J. Control Rel. 25:1993;217-225.
179. Shu X.Z., Zhu K.J. Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. J. Microencapsul. 18:2001;237-245.
180. Shu X.Z., Zhu K.J. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int. J. Pharm. 233:2002a;217-225.
181. Shu X.Z., Zhu K.J. The release behavior of brilliant blue from calcium-alginate gel beads coated by chitosan: the preparation method effect. Eur. J. Pharm. Biopharm. 53:2002b;193-201.
182. Singh U.V., Udupa N. Methotrexate loaded chitosan and chitin microspheres - in vitro characterization and pharmacokinetics in mice bearing Ehrlich ascites carcinoma. J. Microencapsul. 15:1998;581-594.
183. Singla A.K., Sharma M.L., Dhawan S. Nifedipine loaded chitosan microspheres: characterization of internal structure. Biotech. Histochem. 76:2001;165-171.
184. Singla A.K., Chawla M. Chitosan: some pharmaceutical and biological aspects - an update. J. Pharm. Pharmacol. 53:2001;1047-1067.
185. Skaugrud O. Chitosan - new biopolymer for cosmetics and drugs. Drug Cosmetic Ind. 148:1991;24-29.
186. Soane R.J., Frier M., Perkins A.C., Jones N.S., Davis S.S., Illum L. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int. J. Pharm. 178:1999;55-65.
187. Stolberg J., Laranjeira M.C., Sanchez M.N., Klug M., Favere V.T. Microspheres of chitosan/poly(vinylalcohol) incorporating tetrasulphonated copper (II) phthalocyanine: preparation and characterization. J. Microencapsul. 16:1999;431-438.
188. Struszczyk, H., Niekraszewicz, A., Owczarek, K., Wishiewska-Wrona, M., 1994. Biodegradation of chitosan. In: Karnicki, Z.S., Wojtascpajak, A., Breziski, M.M., Bylowsky, P.J. (Eds.), Chitin World. Brenerhaven Wirtschaftsverlag, pp. 555-561.
189. Tachihara K., Onishi H., Machida Y. Preparation of silver sulfadiazine-containing spongy membranes of chitosan and chitin-chitosan mixture and their evaluation as burn wound dressings. Arch. Practical Pharm. 57:1997;159-167.
190. Takahashi T., Takayama K., Machida Y., Nagai T. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int. J. Pharm. 61:1990;35-41.
191. Takishima J., Onishi H., Machida Y. Prolonged intestinal absorption of cephradine with chitosan-coated ethylcellulose microparticles in rats. Biol. Pharm. Bull. 25:2002;1498-1502.
192. Tapia C., Buckton G., Newton J.M. Factors influencing the mechanism of release from sustained release matrix pellets, produced by extrusion/ spheronization. Int. J. Pharm. 92:1993;211-218.
193. Thanoo B.C., Sunny M.C., Jayakrishnan A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J. Pharm. Pharmacol. 44:1992;283-286.
194. Tokumitsu H., Ichikawa H., Fukumori Y., Block L.H. Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique. Chem. Pharm. Bull. (Tokyo). 47:1999;838-842.
195. Upadrashta S.M., Katikaneni P.R., Nuessle N.O. Chitosan as a tablet binder. Drug Dev. Ind. Pharm. 18:1992;1701-1708.
196. Vitrexakis T., Boadi D.K., Quong D., Groboillot A., O'Neill I., Poncelet D., Neufeld R.J. Microencapsulation of DNA within alginate microspheres and cross-linked chitosan membranes for in vivo applications. Appl. Biochem. Biotechnol. 50:1995;93-106.
197. Vural I., Kao H.S., Hincali A.A. Indomethacin microspheres. I. Formulation and in vitro evaluation. Chimica Oggi. 9:1991;49-52.
198. Vural I., Kas H.S., Hincal A.A. Chitosan-treated albumin microspheres of sulfasalazine. Part 1. Formulation and in vitro release profiles. Hacettepe Universitesi Eczacilik Fakultesi Dergisi. 14:1994;57-65.
199. Wan L.S., Lim L.Y., Soh B.L. Drug release from chitosan beads. STP Pharm. Sci. 4:1994;195-200.
200. Wang Y.M., Shi T.S., Pu Y.L., Zhu J.G., Zhao Y.L. Studies on preparation and characteristics of cisplatin chitosan microspheres. Yao Xue Xue Bao. 31:1996a;300-305.
201. Wang Y.M., Sato H., Adachi I., Horikoshi I. Optimization of the formulation design of chitosan microspheres containing cisplatin. J. Pharm. Sci. 85:1996b;1204-1210.
202. Wong T.W., Chan L.W., Kho S.B., Sia Heng P.W. Design of controlled-release solid dosage forms of alginate and chitosan using microwave. J. Control Rel. 84:2002;99-114.
203. Wu W.Y., Li Y.G. Preparation of genistein-loaded chitosan microspheres. Zhongguo Zhong Yao Za Zhi. 27:2002;353-355.
204. Yamada T., Onishi H., Machida Y. In vitro and in vivo evaluation of sustained release chitosan-coated ketoprofen microparticles. Yakugaku Zasshi. 121:2001;239-245.
205. Yoshino T., Machida Y., Onishi H., Nagai T. Preparation and characterization of chitosan microspheres containing doxifluridine. Drug Dev. Ind. Pharm. 29:2003;417-427.